1Katre NV,Asherman J,Schaffer H,et al.Multivesicular liposome(DepoFoam) technolofy for the sustained delivery of insulin-like growth factor-I (IGF-I)[].Journal of Pharmacological Sciences.1998
3Kafedjiiski K, Krauland AH, Hoffer MH, et aI.Synthesis and in vitro evaluation of a novel thiolated chitosan.Biomaterials 2005;26(7):819-826
4Torrado S, Prada E de la Torre PM,et al.Chitosan- poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 2004;25(5):917-923.
5Hofer C , Hartung R , Gobel R , et al. New ultradeform able drug carders for potentialtransderm alapplication of interleukin-2 and interferon-alpha: theoretic and practicalaspects.World J Surg 2000;24(10): 1187-1189.
6Cevc G , Gebauer D , Sfieber J, et al. UItraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.Biochim Biophys Acta 1998; 1368(2):201-215.
7Kim S, Turker MS, Chi EY, et al. Preparation of multivesicular liposomes. Biochim Biophys Acta 1983;728(3):339-348.
8Kim T, Kim J, Kim S. Extended-release formulation of morphine for subcutaneous administration. Cancer Chemother Pharmacol 1993;33(3):187-190.
9Yaksh TL, Provencher JC, Rathbun ML, et al. Safety assessment of encapsulated morphine delivered epidurally in a sustained-release multivesicular liposome preparation in dogs. Drug Deliv 2000;7(1): 27-36.
10Kricheldorf HR. Syntheses and application of polylactides. Chemosphere 2001 ;43 ( 1 ) : 49-54.
